On Friday, Vanda Pharmaceuticals Inc. (VNDA) stock saw a modest uptick, ending the day at $4.91 which represents a slight increase of $0.17 or 3.59% from the prior close of $4.74. The stock opened at ...

StockNews.com upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a sell rating to a hold rating in a ...

Scotiabank started coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) in a research report sent to investors on Wednesday, MarketBeat.com reports. The firm issued a sector ...

Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...

CME Group Inc. is amping up the battle for market share in US Treasury futures, pulling all stops to thwart Howard Lutnick’s ...

Vertex's diverse pipeline positions it for a growth, despite challenges in launching new drugs like Casgevy and suzetrigine.

Closely-watched cases could have implications for areas of corporate law that have come up repeatedly in attorneys' ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

In Arizona, older people recently received a mailer declaring Medicare had been cancelled. It had a big red stamp that ...